US BANCORP \DE\ - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 212 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$28,352
-57.0%
32,000
-23.6%
0.00%
Q3 2022$66,000
-10.8%
41,880
+13.1%
0.00%
Q2 2022$74,000
-23.7%
37,034
-11.4%
0.00%
Q1 2022$97,000
-34.9%
41,810
+31.2%
0.00%
Q4 2021$149,000
-23.6%
31,869
+24.5%
0.00%
Q3 2021$195,000
-22.3%
25,600
-0.9%
0.00%
Q2 2021$251,000
+28.7%
25,840
+10.0%
0.00%
Q1 2021$195,000
+62.5%
23,490
+33.3%
0.00%
Q4 2020$120,000
-36.8%
17,627
+3.4%
0.00%
Q3 2020$190,000
+156.8%
17,046
+46.3%
0.00%
Q2 2020$74,00011,6540.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 15,001$1,4100.00%
KLCM Advisors, Inc. 20,000$1,8800.00%
AlphaMark Advisors, LLC 3,135$00.00%
TRUST CO OF VERMONT 204$190.00%
SlateStone Wealth, LLC 30,866$30.00%
Coppell Advisory Solutions LLC 100$890.00%
Highlander Capital Management, LLC 1,200$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Russell Investments Group, Ltd. 266$250.00%
OGOREK ANTHONY JOSEPH /NY/ /ADV 3,600$00.00%
View complete list of SORRENTO THERAPEUTICS INC shareholders